The contribution of glucagon to hyperglycaemia has been underscored by several recent studies: glucagon receptor deletion prevented diabetes from streptozotocin-induced insulin-deficiency in mice7, whilst glucagon receptor antagonism reduced blood glucose in insulin-resistant mice8 and humans with T2D9. The gene discussed is GCGR; the disease is diabetes mellitus.